Expression levels of IGF-1 and VEGF in the bile and serum of extrahepatic cholangiocarcinoma, pancreatic cancer, and benign biliary abnormalities were measured to evaluate their role as a tumor marker (57). This evidence concerns the gene VEGFA and neoplasm.